SCREENING TEST FOR DETECTING THE PRESENCE OF ONCOGENIC HPV VIRUSES

The screening test and process for detecting the presence of oncogenic HPV viruses, in particular based on LNA (locked nucleic acids) technology, are effective tools in the prevention and early detection of cervical cancer. Probes for use in HPV detection by real time PCR target a conserved region o...

Full description

Saved in:
Bibliographic Details
Main Authors PODOLSKI Jacek, WYRWICZ Lucjan
Format Patent
LanguageEnglish
Published 02.02.2017
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The screening test and process for detecting the presence of oncogenic HPV viruses, in particular based on LNA (locked nucleic acids) technology, are effective tools in the prevention and early detection of cervical cancer. Probes for use in HPV detection by real time PCR target a conserved region of oncogenic HPV genomes.
Bibliography:Application Number: US201515303503